Skip to main content
Year archive

SinoMab BioScience Limited — 2026 filings

All 21 regulatory filings released by SinoMab BioScience Limited (3681) in 2026, sourced directly from the official regulator.

21 Filings
2026 Period
2026 filings (21)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings
2026-06-04 English
VOLUNTARY ANNOUNCEMENT PRESENTATION OF PRECLINICAL STUDIES OF ANTI-CGC ANTIBODY (hC2) AT SID ANNUAL MEETING 2026
Regulatory Filings
2026-05-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
2025 Environmental, Social and Governance Report
Environmental & Social Information
2026-04-27 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement
2026-04-27 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement
2026-04-27 English
NOTICE OF 2026 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2026-04-27 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 3, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON FRIDAY, 12 JUNE 2026 AT 10:00 A.M.
Proxy Solicitation & Information Statement
2026-04-27 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED ELECTION OF A DIRECTOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2026-04-27 English
Annual Report 2025
Annual Report FY 2025
2026-04-27 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF SM17 FOR ATOPIC DERMATITIS IN CHINA
Regulatory Filings
2026-04-01 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2026-04-01 English
VOLUNTARY ANNOUNCEMENT TOPLINE RESULTS FROM PHASE 1 BRIDGING STUDY FOR ROUTE OF ADMINISTRATION CONVERSION OF SM17 IN CHINA
Regulatory Filings
2026-03-25 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2026-03-24 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025; AND CHANGE IN USE OF PROCEEDS
Earnings Release FY 2025
2026-03-23 English
CONNECTED TRANSACTION - TERMINATION OF LEASE AGREEMENT
Regulatory Filings
2026-03-12 English
DATE OF BOARD MEETING
Report Publication Announcement
2026-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings
2026-03-05 English
VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR IBD OF SM17 BY NMPA
Regulatory Filings
2026-02-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Regulatory Filings
2026-01-07 English